The high price of cancer drugs in the US relative to European countries with universal health care raises ethical issues of access, financial burden on patients, and unsustainability of the health care system.
AMA J Ethics. 2015;17(8):750-753. doi:
10.1001/journalofethics.2015.17.8.nlit1-1508.
Because knowledge about the efficacy of long-term opioid use is lacking, decisions about opioid treatment for chronic nonmalignant pain should be guided by a six-step decision making process that is based in clinical ethics.
AMA J Ethics. 2015;17(6):521-529. doi:
10.1001/journalofethics.2015.17.6.nlit1-1506.